Treatment of Advanced Solid Tumors With TSA-CTL(Tumor Specific Antigen-Induced Cytotoxic T Lymphocytes)

ABSTRACT: The primary objective of this study is to evaluate the safety of TSA-CTL in the treatment of advanced solid tumors. The secondary objective of this study is to evaluate preliminarily the effect of TSA-CTL in the treatment of advanced solid tumors.

DISEASE(S): Colorectal Cancer,Solid Cancer

PROVIDER: 2229539 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR